Par Drugs and Chemicals Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 169.16 million compared to INR 162.72 million a year ago. Revenue was INR 169.67 million compared to INR 163.03 million a year ago. Net income was INR 21.15 million compared to INR 20.83 million a year ago. Basic earnings per share from continuing operations was INR 1.72 compared to INR 1.695 a year ago. Diluted earnings per share from continuing operations was INR 1.72 compared to INR 1.695 a year ago.
For the nine months, sales was INR 529.94 million compared to INR 445.39 million a year ago. Revenue was INR 531.11 million compared to INR 446.25 million a year ago. Net income was INR 67.91 million compared to INR 71.94 million a year ago. Basic earnings per share from continuing operations was INR 5.52 compared to INR 5.845 a year ago. Diluted earnings per share from continuing operations was INR 5.52 compared to INR 5.845 a year ago.